Literature DB >> 4574056

Phase II evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in patients with solid tumors.

G Ramirez, W Wilson, T Grage, G Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4574056

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

Review 1.  Systemic therapy of malignant melanoma.

Authors:  J Hansson
Journal:  Med Oncol       Date:  1997-06       Impact factor: 3.064

2.  Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).

Authors:  G J Hill; R Ruess; R Berris; G W Philpott; P Parkin
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

Review 3.  The history and future of chemotherapy for melanoma.

Authors:  Arvin S Yang; Paul B Chapman
Journal:  Hematol Oncol Clin North Am       Date:  2009-06       Impact factor: 3.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.